Christophe Richez

Trial of Anifrolumab in Active Systemic Lupus Erythematosus

Eric F. Morand, Richard Furie, Yoshiya Tanaka et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco et al. · Annals of the Rheumatic Diseases · 2021 · 682 citations · Full text

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

Pierre‐Antoine Juge, Joyce Lee, Esther Ebstein et al. · New England Journal of Medicine · 2018 · 475 citations · Full text

Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study

Marie Kostine, L. Rouxel, Thomas Barnetche et al. · Annals of the Rheumatic Diseases · 2017 · 293 citations

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Jérôme Avouac, Élodie Drumez, É. Hachulla et al. · The Lancet Rheumatology · 2021 · 290 citations · Full text

Rheumatoid Disorder, Rheumatology, Autoimmune Disease +9